SynthesisPathology oncology research : POR2018

COL1A2 is a Novel Biomarker to Improve Clinical Prediction in Human Gastric Cancer: Integrating Bioinformatics and Meta-Analysis.

Li Rong et al.PubMed ↗Publisher ↗

No numbers read from the abstract.